By March 1987, 31526 adult cases of acquired immune deficiency syndrome (AIDS)1 had been reported in the USA and 456 paediatric cases. In the UK, 750 cases were reported but 25 times this number are human immunodeficiency virus (HIV) positive and it is estimated that approximately 12% of those seropositive will go on to develop AIDS.
Kaposi's sarcoma is the presenting feature ofAIDS in over a quarter of homosexual men and occurs in upto 45% of homosexual AIDS patients, although it is present in less than 10% of other risk groups. Kaposi's sarcoma alone has the best prognosis; the median survival for patients with AIDS Kaposi's sarcoma2 is 21.2 months in the absence of opportunistic infections and 12.5 in those with Pneumocystis carinii and 6.6 months in those with both. We would like to report two homosexual patients with Kaposi's sarcoma who illustrate the potentially long survival of such patients.
Case reports Case 1 Presented in 1980 with Kaposi's sarcoma on the left leg. A venogram suggested involvement of the left calf veins and lymphocyte studies showed an increased suppressor cell population. He was irradiated with a long field from the mid-thigh to the toes using 8 MeV electrons and received 22.5 Gy in 10 daily fractions. In 1985 he developed a new Kaposi's sarcoma on the same leg managed by excision biopsy followed by radiotherapy. Human T-cell lymphotropic virus (HTLV E) was equivocal. He received 2o Gy using 5 MeV electrons in 10 fractions.
A month later a repeat HTLV m was positive, his helper/suppressor ratio was reversed and he had developed Kaposi's sarcoma ofthe scrotum. These were irradiated using 20 Gy and a further 10 Gy to localized lesions. Later the same year he developed further lesions on the hands, palate and feet. The most troublesome lesions on the right foot and elbow were bleeding and therefore irradiated, both receiving 30 Gy although using different machines, numbers of fractions and overall time. All treated lesions regressed. In January 1986 a lesion was excised from the conjunctiva and Kaposi's sarcoma on the right alae nasii irradiated with 10 MeV electrons. In the same year various lesions on the hands were irradiated using 7 MeV electrons.
He now had widespread Kaposi's sarcoma but no evidence of opportunistic infections and his general condition is good. Case 2: A 47-year-old practising homosexual presented in 1981 with Kaposi's sarcoma ofthe left foot. He had a past history ofhepatitis B, gonorrhoea and syphilis and a history of amyl nitrate inhalation. The lesion was managed by excision biopsy and a further Kaposi's sarcoma lesion excised in 1982. In 1983 he presented with an isolated new nodule on the left foot and this was irradiated and received a cancerocidal dose of 50 Gy using 5 MeV electrons in 10 daily fractions. He had no evidence of opportunistic infections. Absolute numbers of helpers and suppressors were normal with a ratio of 1.25. He remained well subsequently with no evidence ofrecurrent Kaposi's sarcoma. In 1984 HTLV m was negative but in October 1986 this was positive with an increased number of suppressor cells and a helper to suppressor ratio of 0.46.
Discussion
These two patients are interesting for a variety of reasons. Their long survival, as an illustration ofthe radiosensitivity of Kaposi's sarcoma in AIDS patients and the usefulness of radiotherapy as a technique to control troublesome lesionsconfirmed by other authors3
Multiple disease sites were treated and required variable doses. Response rates varied within and between individuals and this may reflect an altered response to radiation because of changes in the immune status. Both patients showed a deterioration of their helper to suppressor ratio, both had increased suppressor cell numbers and Kaposi's sarcoma antedated the development ofHIV positivity. Solitary lesions often have long relapse free intervals and seem to have a better prognosis. Whether these patients constitute part of 0141-0768/89/ 040226-02/$02.00/0 ©1989 The Royal Society of Medicine a pre-AIDS syndrome remains uncertain but recognition of this better prognostic group is clearly important.
The occurrence of Kaposi's sarcoma in the presence of normal helper cells and the absence of HIV positivity raises questions as to the direct role ofHTLV m in the pathogenesis of Kaposi's sarcoma. It is interesting that the percentage of Kaposi's sarcoma amongst the AIDS patients is decreasing whilst the AIDS population increases. The incidence of Kaposi's sarcoma is different in sub-populations of AIDS patientsthose acquiring AIDS by blood innoculation having a low incidence of Kaposi's sarcoma. Recent studies link cytomegalovirus4 with Kaposi's sarcoma in non-homosexual patients. Afrasiabil reported three male homosexuals with Kaposi's sarcoma and AIDS with normal helper to suppressor ratios who were negative for HTLV m in a group of 97 patients with epidemic Kaposi's sarcoma. We report a patient who suffered from myotonic dystrophy and parathyroid hyperplasia, an association which, to our knowledge, has not previously been described.
Case report A 52-year-old woman (RNSH 681329) with a 23 year history of muscular weakness was admitted because of drowsiness and dehydration. Muscular weakness had been present since age 29. At the age of 33 years, myotonic dystrophy was diagnosed on the basis ofclinical findings, electromyography and muscle biopsy. Subsequent family studies revealed myotonia in one sister (who is normocalcaemic), this sister's daughter and in three of the patients' four children. Approximately 8 months before admission, the patient developed nausea, vomiting and increasing weakness. At operation (Dr L Delbridge), four enlarged parathyroids were found. The left upper gland weighed 3.9 g and contained a large oxyphilic nodule. The two lower glands were also removed. These weighed 0.10 and 0.129 g, respectively, and histological examination was interpreted as showing hyperplastic changes. The fourth gland was thought to be only slightly enlarged and was left in the neck.
Postoperative recovery was unremarkable with consistently normal serum calcium and serum PTH concentrations. After the operation the patient reported subjective improvement in her muscle strength, although there have been no objective changes on muscle testing.
Myotonic dystrophy is an autosomal dominant disorder with characteristic changes ofmuscle weakness, myotonia, cataracts and frontal balding2. Endocrine disturbance associated with this disease include insulin resistance3, abnormal thyrotrophic hormone responses to thryotrophin-releasing hormone4 and a reduction in adrenal androgens5. However, while there is a well known association between muscle weakness and hyperparathyroidism5, we know of no association between myotonic dystrophy and hyperparathyroidism. In a group of265 patients with primary hyperparathyroidism previously reported from this unit7 there were no cases of myotonic dystrophy. Moreover, a study of 23 patients with myotonic dystrophy8 found normal serum calcium in all of them and normal serum immunoreactive parathyroid hormone values in all but one in whom there was a marginal elevation.
While a single case may obviously be due to a chance association, the co-existence ofthese two disorders may throw further light on the intriguing endocrine abnormalities seen in myotonic dystrophy.
